Information Provided By: 
Fly News Breaks for June 14, 2019
SUVPF, BIO
Jun 14, 2019 | 08:29 EDT
Jefferies analyst Brandon Couillard says the risk/reward on Bio-Rad Laboratories (BIO) looks "increasingly attractive." The shares have decoupled from both Sartorius (SUVPF) and peers of late, and its Sartorius stake is now worth $4.3B, or a record 50% of its market capitalization, Couillard tells investors in a research note. He believes concerns around Bio-Rad's "tough" Q2 comp seem overblown and that investor patience will be rewarded. Couillard keeps a Buy rating on the shares with a $400 price target.
News For BIO;SUVPF From the Last 2 Days
There are no results for your query BIO;SUVPF
